The innovative research conducted by our physicians and faculty has paved the way for more effective methods of prevention, diagnosis, and treatment of gastrointestinal diseases.
In our mission to create knowledge through research, the Division of Gastroenterology and Hepatology continues to conduct cutting-edge investigations of the molecular, cellular, and physiological conditions of healthy and diseased states of the gastrointestinal tract, liver, and pancreas. The central piece of the Division's research endeavor is the NIH-funded University of Michigan Center for Gastrointestinal Research, which encompasses three thematic areas of research:
- neurobiology of appetite control and visceral pain
- molecular and cellular mechanisms of inflammation
- cell growth, differentiation, and programmed cell death
Nobuhiko Kamada, PhD and Shrinivas Bishu, MD discuss their new study that describes how poor oral health may worsen gut inflammation.
Grace Su, MD weighs in on probiotics and whether or not they help digestive conditions like Crohn's disease, ulcerative colitis, or irritable bowel syndrome.
Sameer Berry, MD, MBA finds that pain scores in patients with inflammatory bowel disease did not improve during hospitalization despite high opioid use.
Marisa Miceli, MD and Peter Higgins, MD, PhD, MSc lead study that focuses on how effective Hydroxychloroquine may be in protecting health care providers.